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Abstract
Studies have been conducted on various factors and their effect on human papillomavirus (HPV)
vaccination uptake amongst adolescents. However, these studies typically point to
communication factors and provider recommendations as having a significant effect on HPV
vaccination uptake, ultimately leading to the need for more information on other factors that may
increase HPV vaccination amongst adolescents. The purpose of this quantitative cross-sectional
study was to determine if race, provider-location type, and region of the United States have a
statistically significant effect on HPV uptake amongst adolescents. The 2018 National
Immunization Survey (NIS) was used, and 34,980 participants were included in the sample. The
theoretical framework used for this study was Hochman and Rosentsock’s Health Belief Model
(HBM). The HBM approach was used to explore the health behavior change process and the
attitudes and perceptions amongst parents that are associated with HPV vaccination uptake
amongst adolescents. Using the cross-sectional design, surveys from the NIS were analyzed
using a binary logistic regression to determine whether race, provider-location type, and region
of the United States have a statistically significant effect on HPV vaccination uptake amongst
adolescents. The results of these analyses indicated that there was a statistically significant effect
amongst race and region. Specifically, the White race residing in the Northeast, Midwest, and
Southern regions were shown to have a statistically significant effect and an upward uptake on
HPV vaccination amongst adolescents. Public health professionals and providers may benefit
from the results of this study by identifying the areas that are shown to have a statistically
significant effect on HPV vaccination uptake among adolescents.
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Chapter 1: Introduction to the Study
Background of the Study
The human papillomavirus (HPV) vaccine is an essential element in the
prevention of cancer and has the ability to save lives. HPV is a vaccine that is needed, but
not always consistently administered. HPV affects approximately 14 million people in the
United States each year and has the ability to cause certain types of cancers in both men
and women (CDC, 2017). The cancers most commonly associated with HPV include
cancer of the cervix, oropharyngeal, vulva, vagina, penis, and anus (CDC, 2017).
HPV is the most common sexually transmitted infection, and due to its
prevalence, it is predicted that all persons that are sexually active will get the virus at a
point in their lives if they have not received the HPV vaccine (CDC, 2017).
Unfortunately, HPV vaccination rates in the United States have consistently staggered in
comparison to other vaccines (CDC, 2017). In 2017, only 49% of adolescents were up to
date on the HPV vaccine, and 66% of adolescent’s ages 13 to 17 received the first dose of
the HPV vaccine series (CDC, 2018). Although research has been conducted on the
communication factors of HPV, there is limited research on the specific factors that affect
HPV vaccine uptake in adolescents. No research was found that looked into determining
whether there were specific factors such as race, geographical region, and providerlocation type in a cohesive manner.
A retrospective analysis of existing data can provide a look into whether there are
factors that affect HPV vaccine uptake among adolescents. The aim of this study was to
determine whether there is an effect between an adolescent’s race, geographical region of

2

the United States, and provider-location type on HPV vaccination uptake amongst
adolescents.
Problem Statement
Vaccine misconceptions occur frequently, and health care providers can play a
significant role in addressing fallacies. Communication about HPV vaccination occurs in
several ways, from direct conversations with providers and nurses to outreach from state
and local health departments (Hendrix, 2015). Currently, no studies exist that aid in
determining the cohesive effect of race, provider-location type, and geographical region
of the United States, on HPV vaccination uptake in adolescents. As mentioned
previously, the aim of this study was to determine the correlational effect of providerlocation type, race, and geographical region to identify trends related to racial disparities
and regional provider health practices regarding HPV vaccine uptake among adolescents.
I sought to create further research through identifying specific strategies related to
reaching all racial groups and identifying regional-provider-locations, through possible
outlining of provider HPV uptake practices in areas of higher uptake.
Purpose Statement
The purpose of this quantitative study was to determine if certain races and
regions of the country have a significant effect on HPV vaccine uptake in adolescents. It
was also important to determine specific racial and relational factors that may lead to a
higher HPV vaccination rate, for further research. Factors may include educational
barriers, socioeconomic factors, provider relationship, and/or outreach initiatives. I
employed a quantitative research methodology using secondary data. I retrieved the data
from the National Immunization Survey (NIS), which is a group of telephone surveys
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sponsored by the Centers for Disease Control and Prevention’s (CDC) National Center
for Immunization and Respiratory Diseases (NCIRD; CDC, 2018).
Research Questions and Hypotheses
RQ1: What is the effect of race and region of the United States on HPV vaccine
uptake in adolescents?
H01: There is no effect of race and region of the United States on HPV vaccine
uptake in adolescents.
H0a: There is a significant effect of race and region of the United States on HPV
vaccine uptake in adolescents.
RQ2: What is the effect of race and provider-location type on HPV vaccine
uptake in adolescents?
H01: There is no effect of race and provider-location type on HPV vaccine uptake
in adolescents.
H0a: There is a significant effect of race and provider-location type on HPV
vaccine uptake in adolescents.
RQ3: What is the effect of region of the United States and provider-location type
on HPV vaccine uptake in adolescents?
H01: There is no effect of region of the United States and provider-location type
on HPV vaccine uptake in adolescents.
H0a: There is a significant effect of region of the United States and providerlocation type on HPV vaccine uptake in adolescents.
RQ4: Does race modify the effect of region of the United States on HPV vaccine
uptake in adolescents?
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H01: Race does not modify the effect of region of the United States on HPV
vaccine uptake in adolescents.
H0a: Race significantly modifies the effect of region of the United States on HPV
vaccine uptake in adolescents.
Nature of the Study
This research examined how race, provider-location type, and region of the
United States affects HPV vaccine uptake among adolescents. Quantitative methods are
more objective than alternative approaches. This approach is consistent with
understanding the research questions. To achieve the anticipated results, the NIS was
used to address the research questions (CDC, 2018). Descriptive statistics were
conducted to summarize the data. Additionally, a Pearson chi-square analysis was
conducted to determine if there is a relationship between the variables, and a binary
logistic regression analysis was conducted to determine the effect of race, providerlocation type, and region of the United States on HPV vaccine uptake among adolescents.
Definition of Terms
The definition of key terms used throughout this study are shown below.
Human Papillomavirus (HPV): A small, double-stranded DNA virus that infects
the epithelium. It is estimated that there are more than 120 HPV types (CDC, 2019). HPV
is also the most common sexually transmitted infection in the United States (CDC, 2019).
Epidemiologic studies showing a consistent association between HPV and cervical cancer
were published in the 1990s (CDC, 2019).
HPV Vaccine: There are three HPV vaccines licensed in the United States (CDC,
2019). The FDA approved the quadrivalent HPV (HPV4) vaccine, also known as
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Gardasil and manufactured by Merck, in 2006 (CDC, 2019). The bivalent HPV (HPV2)
vaccine, also known as Cervarix, was approved by the FDA and manufactured by
GlaxoSmithKline in October 2009 (CDC, 2019).
Race: The Census Bureau defines race as “a person's self-identification with one
or more social groups” (Census.gov, 2017). An individual can report to be White, Black
or African American, Asian, American Indian and Alaska Native, Native Hawaiian and
Other Pacific Islander, or some other race (Census.gov, 2017).
Provider-location type: For the purpose of this research study, provider-location
type is defined as a place in which a vaccine is administered, which may include a
hospital, health department, doctor’s office, pharmacy, etc.
Geographical/Census Region of the United States: A region is an area of land that
has common features. Regions of the United States are commonly grouped into five
geographic locations: The Northeast, Southwest, West, Southeast, and Midwest (National
Geographic, 2019).
Theoretical Framework
The Health Belief Model (HBM) developed by Hochman and Rosenstock was
ideal for this study because it allows researchers to understand the health behavior change
process. The HBM was developed to identify the attitudes of parents and providers
toward HPV vaccination and what types of provider-locations, races, and geographical
regions may affect those attitudes. Factors such as low risk perception may be a barrier to
HPV vaccine uptake amongst adolescents; therefore, it was important to identify the
effects of certain factors that may lead to understanding the barriers, benefits, selfefficacy and threats that affect HPV vaccine uptake amongst adolescents are of most
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importance (Jones, Jensen, Scherr, & et al , 2015). The HBM implies that a specific
health action will prevent or cure illness (LaMorte, 2018). There are several constructs
that comprise the HBM: perceived susceptibility, a parent’s perception of the risk of the
HPV vaccine; perceived severity, the parent’s feelings on the seriousness of their child
contracting HPV; perceived benefits, the parent’s perception of the effectiveness of
vaccination; perceived barriers, a parent’s feelings towards the obstacles to receiving the
HPV vaccine; and cue to action, the need to trigger the parent to make the decision to
vaccinate child against HPV.
Significance
Healthcare providers play an important role in educating patients and parents on
the importance of HPV vaccination. Studies have consistently shown that non-existent or
weak recommendations from health care providers are primary determinants of poor
vaccine uptake (Ventola, 2016). As a result, it is important to develop interventions that
target health care providers and their practices, including patient counseling, vaccine
forecasting, and reminder systems (Ventola, 2016). In order to determine what providers
are more effective in educating and administering HPV vaccination in adolescents, it was
important to understand what type of provider-location types and what regional areas of
the country were more successful in HPV uptake. It was also equally vital to determine
the racial barriers associated with HPV vaccine. Race-specific factors can help or hinder
vaccination rates in certain areas. It was also important to determine whether there was a
relationship between certain provider-location types and race. The aim of this study was
to open the path for further research in health promotion, identifying barriers, and
determining why certain provider-location types are more successful than others are.
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Implications for Social Change
Social change is about making a positive impact on society (Walden University,
2017). The potential social change impact of this study was the prevention of cancer.
Strengthening the overall understanding of the impact of HPV prevention is important for
fostering positive social change. Identifying specific racial barriers and provider-locations
most affected while creating specified ways to increase HPV vaccination rates around the
country will aid in preventing HPV-related cancer deaths of citizens of the United States,
which in turn will aid in preventing HPV-related cancer deaths around the world. This
study sought to create the ultimate positive impact on society through saving lives.
Assumptions
When discussing the assumptions of this study, it was important to factor in the
characteristics of the data, as well as the sample size. The study’s sample may not be
representative of the population; however, it was my assumption that the sample size was
a good representation of the population. I also assumed that individuals completing the
survey were being truthful and that answers received at the time of the survey were
verified for accuracy.
Scope and Delimitations
The scope of this study included parents of adolescent children across the United
States. This group was targeted due to the age in which adolescents are recommended to
receive the HPV vaccine, which is the ages of 11 and 12. The age group of this sample is
13 to17 which falls after the recommended age, to factor in adolescents who may have
received the vaccination after the recommended age. I did not include younger age
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groups because they would not apply to the recommended age for HPV vaccine
acquisition, therefore causing issues with validity.
Limitations
The limitations of this study included the inability to conclusively attribute race,
geographical region of the United States, and/or provider-location type to an increased
uptake in HPV vaccination. An additional limitation of this study was that the sample
was not representative of the entire population. It is important to understand this
limitation as the NIS does not survey the entire population. Additional barriers may have
been produced as a result of inaccurate reporting, which would reduce validity.
Summary
This chapter discussed the causality and etiology of HPV. This chapter also
explored the importance of the HPV vaccine and the growing concern regarding the low
uptake amongst adolescents. HPV can adversely affect so many lives, however, we are
fortunate to have developed a vaccine that is available to adolescents. We are also
fortunate to have a public health advance with the use of the HPV vaccine that can
prevent HPV and ultimately varying types of cancers in all genders. HPV vaccine
administration falls behind other recommended vaccines but has the potential to prevent
frequent infection and save lives. Therefore, it was important to understand the factors
and barriers that may affect the uptake in adolescents. This study was aimed at
identifying the effects and significance of such factors.
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Chapter 2: Literature Review
Introduction
HPV is the most common sexually transmitted infection in the United States and
has the ability to cause frequent infection and several forms of cancer (Centers for
Disease Control and Prevention, CDC, n.d.). HPV vaccination rates in the United States
remain low compared to other recommended vaccines such as Tdap. There are several
factors that contribute to the low uptake of HPV vaccination. The purpose of this
literature review was to understand and expand on the existing knowledge surrounding
the factors effecting HPV vaccine uptake in adolescents.
This literature review discusses the theoretical framework relevant to this study,
the etiology of HPV, and the mode of prevention. I intended to identify racial and
regional factors that influence HPV uptake in adolescents as revealed in previous studies.
The literature review also looks into HPV, vaccination strategies, and physician
recommendation. There was insufficient research that identified provider-location type
and its effect, if any, on HPV uptake in adolescents in the United States. There was also
no research found regarding the aforementioned factors cohesively having an effect on
HPV uptake amongst adolescents. This literature review also details overall findings and
trends to gain a better understanding of what previous research discovered.
Literature Search Strategy
My review of the literature identified scholarly articles published between 2015
and 2020. To conduct the literature review, I searched the Walden University Library
along with the following online databases: ProQuest, MEDLINE, PubMed, EBSCOHost,
SAGE Publications, and Google Scholar. The database search was conducted using a
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Boolean search string composed of the following key terms: HPV, human papillomavirus
vaccine, HPV vaccine uptake AND adolescents AND barriers, HPV Vaccine uptake AND
race AND adolescents, HPV vaccine uptake AND adolescents AND provider location
type, HPV Vaccine uptake AND adolescents AND geographical region, and HPV vaccine
uptake AND United States. Various other articles were located using the references of
related studies.
The literature screening process included reviewing the abstracts of each article to
determine if it met the criteria for inclusion in this literature review. Articles were
excluded based on the following factors: if they were published prior to 2015, if the study
was conducted outside of the United States, and if the article was not relevant to HPV
vaccination uptake. Articles that were reviewed in their entirety provided insight into the
research that has been conducted surrounding the topic of this dissertation.
Theoretical Framework
The HBM was the ideal theoretical framework for this study. The HBM was
developed to understand the process of health behavior (Rosenstock, 1974). The HBM
was created from independent and applied public health service research problems
between 1950-1960, and as practical problems were solved, the HBM evolved
(Rosenstock, 1974). In the 1950s, patient compliance and physician-patient
communication were not a consideration of the public health realm, and during this time,
individuals often did not comply with disease prevention measures and test screenings for
conditions such as cervical cancer (Rosenstock, 1974). The HBM was ultimately
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developed to address these factors by explaining and targeting preventative behavior
prior to the potential onset of disease (Rosenstock, 1974).
The HBM will aid in identifying the attitudes of parents and providers toward
HPV vaccination as a preventative measure and will ultimately identify how the specified
factors may affect the proposed and intended behavior change. The HBM will assist in
addressing the importance of targeted audiences, provider-relationship, and rapport, and
could indicate whether knowledge, accessibility, race, region, and provider-location lead
to a higher uptake of HPV vaccine amongst adolescents. Table 1 depicts the constructs in
relation to HPV vaccine uptake regarding this study.
Table 1
Health Belief Model Constructs
Theoretical framework
(HBM)
constructs
Perceived susceptibility

Definition

Application

A person’s perception of the
risk of acquiring a disease.

Parents’ perception of
adolescent child acquiring HPV,
due to factors of race,
geographical location, and
provider-location type.

Perceived severity

A person’s feelings on the
seriousness of contracting a
disease

Parents’ feelings on the severity
of their adolescent child
contracting HPV, which may be
affected by factors such as race,
geographical location, and
provider-location type.

Perceived benefits

A person’s perception of the
effectiveness of various
actions available to reduce
the threat of illness or
disease

Factors that may affect the
parent’s perception of the
effectiveness of the HPV
vaccine to reduce the threat if
infection.
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Perceived barriers

A person’s feelings on the
obstacles to performing a
recommended health action.

Factors contributing to the
obstacles to acquiring HPV
vaccination for their adolescent
child.

Cues to action

Stimulus needed to trigger the Strategies to trigger the decision
decision-making process to
to acquire the HPV vaccine for
accept a recommended health adolescent child.
action.

Self-efficacy

The level of a person’s
confidence in his or her
ability to successfully
perform a behavior.

Parents’ confidence in their
ability to successfully have their
adolescent child vaccinated.

(Rosenstock, 1974).
Previously, the HBM had been used to predict a health behavior based on a
person feelings, knowledge, beliefs, or attitudes. For instance, the HBM was used to
investigate the effect of educational programs on nursing students’ health beliefs and
practices of breast self-examination (Kissal & Kartal, 2019). Other researchers have used
it to explore the predictors of Haitian men’s intention to screen for prostate cancer (Louis,
2019). It has been found that education has a positive influence on the frequency of
breast self-examination, the HBM will aid in understanding how a person’s knowledge
can influence behavior change (Kissal & Kartal, 2019). It has also been found that culture
can be a barrier to individual’s decision to screen for prostate cancer (Louis, 2019).
The HBM provides a process of behavior change evolution. It begins with the
belief or attitude, followed by education and knowledge, and finally by confidence and
ability. It facilitated understanding of the attitudes towards HPV and how specific factors
affected those attitudes, cohesively. Understanding how race, geographical location, and
provider-location type affect a parent’s choice to vaccinate was important. The
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aforementioned assisted in identifying strategies and interventions that can be used to
increase vaccination amongst the barriers and to identify a target population to reach this
feat.
Review of Literature Related to Key Variables and Concepts
Human Papillomavirus Information
HPV are double-stranded DNA viruses that infect the basal, cutaneous, and
mucosal epithelium. Of the more than 120 HPV types, 40 types infect the mucosal
epithelium and have been found to correlate with cervical carcinoma (CDC, n.d.). There
are over 13 cancerous high-risk HPV types, with 70% of cervical cancer being attributed
to types 16 and 18, accounting (Ault, 2006). HPV infection incidence is high and
typically asymptomatic, however the virus generally heals on its own, while some other
individuals become persistently infected which increases the risk for cervical cancer
development, with the most significant being the cervical intraepithelial neoplasia, or
CIN (Ault, 2006). The CIN can range from low-grade CIN 1 to high-grade CIN 3; the
higher the grade, the higher the risk of cancer (Ault, 2006). In low-grade lesions, HPV is
in episomal form, while in high-grade lesions and cancer, the HPV DNA is typically
integrated into the host-cell chromosome (Ault, 2006). Figure 1 provides more
information on HPV infection.
The clinical manifestations of HPV infection include genital warts, recurrent
respiratory papillomatosis, cervical cancer precursors, and various cancers including
cervical, anal, vaginal, vulvar, penile, and oropharyngeal (CDC, n.d.).
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Figure 1. Human papillomavirus.
(Centers for Disease Control and Prevention, n.d.).
Human Papillomavirus Prevalence and Transmission
There are approximately 79 million people in the United States currently infected
with HPV, with sexual activity being the major risk factor for infection (CDC, n.d.). HPV
spreads by direct sexual contact, and it is believed that by age 50, 80% of women will
contract HPV infection (Ault, 2006). Figure 2 shows the natural history of HPV infection.
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Figure 2: Natural history of HPV infection.
(Centers for Disease Control and Prevention, n.d.).
HPV Vaccination Information
Currently, there are three vaccines that prevent infection with disease-causing
HPV types: quadrivalent vaccine Gardasil, nonavalent vaccine Gardasil 9, and bivalent
vaccine Cervarix, all are licensed for use in the United States (Cancer.gov, 2019). Each of
these vaccines prevent infection with the two high risk HPV types, 16 and 18. Gardasil
prevents infection with HPV types 6 and 11, while Gardasil 9 prevents infection with the
same four HPV types plus five additional cancer-causing types (31, 33, 45, 52, and 58)
(Cancer.gov, 2019). Currently, Gardasil 9 is the only HPV vaccine available for use in
the United States (Cancer.gov, 2019).
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United States ACIP HPV Vaccination Recommendation
The Advisory Committee on Immunization Practices (ACIP) develops
recommendations on vaccination to prevent and control vaccine preventable diseases in
the United States. Once the ACIP formulates the recommendations the CDC director
reviews the recommendations for approval, once approved the recommendations are
published and adopted. (CDC, 2019). The ACIP recommends that HPV vaccination
should be administered at the age of 11 or 12 years, however, vaccination can be started
as early as age 9 years. HPV vaccination is recommended for all persons through age 26
years who were not adequately vaccinated earlier (CDC, 2019). The Healthy People 2020
target goal for adolescent HPV vaccination is 80% (National Vaccine Advisory
Committee, 2016).
Studies on HPV Vaccine and Physician Recommendation
It has been proven across the literature that provider recommendations are one of
the most important elements of HPV vaccine uptake amongst adolescents. Provider
recommendations are not given consistently, the recommendations may not be timely,
which increases missed opportunities, and are often not considered urgent, in regard to
strong recommendations in receiving the vaccine prior to exposure to the infection
(Sriram & Ranganathan, 2019). Researchers found that adolescents who are not
recommended for vaccination by the family physician were 0.43 times less likely to get
HPV vaccination compared to adolescents that were recommended to get the vaccination
by the provider p = 0.000, OR 0.57, 95% CI [0.49, 0.65] (Sriram & Ranganathan, 2019).
Shawhan and Ruppe (2019), mentioned that a firm and consistent
recommendation in favor of vaccinating for HPV, should be completed at every
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opportunity to vaccinate and should be offered to patients just as other recommended
vaccines (Shawhan & Ruppe, 2019). According to the 2015 study of National
Immunization Survey–Teen national survey data, a significant predictor of HPV vaccine
uptake was attributed to provider recommendation, even with patients and/or parents
having common knowledge of the vaccine (Shawhan & Ruppe, 2019). Valentino and
Poronsky (2016), mentioned that providers often fail to recommend HPV vaccination for
adolescents, and typically provide weaker recommendations for HPV vaccination
compared with other vaccinations recommended for adolescents; ultimately diminishing
its importance (Valentino, & Poronsky, 2016).
According to a study, provider recommendations among females were highest
among non-Hispanic whites, while provider recommendations among males were lowest
among non-Hispanic whites (Burdette et al, 2017). Hanson et al. (2019) mentioned that at
follow-up, 65% of survey respondents reported receiving an HPV vaccine
recommendation from a healthcare provider, 56% of respondents reported discussing
HPV vaccine with their parents, and 55% had initiated the HPV vaccine series (Hanson,
McLean, Belongia, & et al., 2019). Loke et al. (2017), mentioned that within the 42
articles of conducted research, one-third reported that a major facilitator of HPV
vaccination among adolescents was the healthcare provider or physician recommendation
(Loke, & et al, 2017). Health care providers were considered to be the most trusted
source of health information for parents and was a major determining factor for the
parents to agree to have their child vaccinated against HPV (Loke, & et al, 2017).
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Studies on HPV Vaccine and Provider-Location Type
Garbutt et al. (2018) indicated that accurate characterization of the facilitators and
barriers to implementation of HPV vaccine recommendations in the primary care setting
has the ability to inform effective implementation strategies (Garbutt, Dodd, Walling & et
al, 2018). A Consolidated Framework for Implementation Research (CFIR) was used to
assess factors the aid in HPV vaccine influence in 10 primary care practices (Garbutt,
Dodd, Walling & et al, 2018). The results showed strongly distinguishing constructs, of
which included knowledge and beliefs, self-efficacy, readiness for change, perception,
and the process to deliver the vaccine (Garbutt, Dodd, Walling, & et al, 2018). These
constructs show the various significant barriers to HPV vaccination at the primary
provider level. There are other provider types that may have the same barriers, and
possibly more. This shows that addressing the HPV vaccine issue will be a multi-step and
multi-prong approach, but first it is important to understand what providers are more or
less successful to identify the strategies that can be adopted to effectively combat the low
uptake of HPV vaccination amongst adolescents.
Katz et al. (2016) indicated that further research should look into strategies are
needed to support providers, including vaccine promotion and delivery while addressing
HPV vaccination concerns for parents (Katz, Bogart, Fu, & et al, 2016). Additional areas
of research include, collaboration at the practice level through standardization of
reminder systems for better efficiency (Garbutt, Dodd, Walling & et al, 2018). Providerlocation has the ability to affect HPV vaccination uptake in adolescents. A study was
conducted that incorporated an intervention bundle to include, empowerment of nurses,
no cost vaccination medical records review, and collaboration (Deshmukh, Oliveira,
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Griggs & et al, 2018). Overall, the implementation of this strategy led to a decrease in
missed opportunities at an OB/GYN clinic and increased the initiation of HPV
vaccination, this increase was significant amongst minority Hispanic, publicly insured
and uninsured women (Deshmukh, Oliveira, Griggs & et al, 2018). This article provided
a great deal of information; even though this was not a study targeted at adolescents, the
strategy could still work amongst minority groups and amongst different providerlocation types. It is important to identify what works, and how to effectively identify the
strategies that have worked according to previous research. This study provided more
details into interventions that can contribute to effectiveness and an increase in HPV
vaccination uptake amongst adolescents (Deshmukh, Oliveira, Griggs & et al, 2018).
Studies on HPV Vaccination Strategies
HPV vaccine strategies can provide insight into increasing HPV vaccination
amongst adolescent while considering a variety of factors. Institutional and policy factors
contribute positively to increasing uptake of HPV vaccine, school-based policies are also
effective in achieving higher vaccination rates, however, this can be very complex with a
vaccine such as HPV because it is not communicable in a school setting (Head,
Biederman, Sturm, & Zimet, 2018). Vaccine policies also play a key role in increasing
the uptake of HPV vaccination, due to efficacy of a 2 dose series, the reduction in the
number of doses of HPV from 3 doses to 2 doses prior to age 15, may contribute to an
increase in uptake as well as, completion of the series. Age-based policies may also
increase the uptake of HPV amongst adolescents, the suggestion of moving the age of
vaccination to an earlier age, may disassociate the vaccine with the initiation of sex
(Head, Biederman, Sturm, & Zimet, 2018). An additional strategy is the countering of
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anti-HPV vaccine rhetoric, HPV vaccine controversies are plentiful, with the belief that
the vaccination will translate to increased sexual activity, and negative beliefs
surrounding the vaccination (Head, Biederman, Sturm, & Zimet, 2018). Technology is
also a great resource for increasing HPV vaccination, eHealth can assist in addressing
HPV vaccination in a clinical setting, for example reminders, and forecasting of
vaccination.
Identifying which providers are using technological platforms such as eHealth can
assist in determining the providers with an increased level of HPV vaccination amongst
adolescents (Head, Biederman, Sturm, & Zimet, 2018). Lastly, community-based
interventions have the ability to increase vaccination among adolescents, effective
communication can change the narrative and negative beliefs associated with the HPV
vaccine; community-based interventions can also target a specific population in a specific
area, amongst different providers, ultimately increasing HPV vaccination rates amongst
adolescents (Head, Biederman, Sturm, & Zimet, 2018). Overall, it is important to identify
strategies that will influence and educate on HPV vaccination. Establishing public policy,
taking advantage of eHealth technologies, and creating effective communication, can
assist in increasing HPV vaccine uptake amongst adolescents. Further research is needed
to determine effective strategies that can lead to increased HPV vaccination, of which a
multifaceted and multipronged approach seems to be ideal and would have the ability to
address several of the barriers to increase HPV vaccine uptake through education, and
changed behavior (Katz, Bogart, Fu, & et al, 2016).
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Studies on HPV Vaccination and Race
There are racial differences as it pertains to HPV vaccination amongst
adolescents. There are variations among different races and the initiation of the HPV
vaccine amongst adolescents. The study showed Hispanic adults were 1.47 times more
likely to get vaccinated compared to non-Hispanic adolescents p = 0.000, OR 1.47, 95%
CI [1.24, 1.74] (Sriram & Ranganathan, 2019). A study also found that Hispanic female
adolescents initiated the HPV vaccine at a higher rate (48%), while African American
adolescents had a lower rate of HPV vaccine initiation (40%) (Burdette, Webb, Hill & et
al, 2017). Additionally, minority adolescent males had a higher rate of HPV vaccine
initiation (12%) while non-Hispanic whites had lower HPV vaccination initiation (24%)
(Burdette, Webb, Hill & et al, 2017). An investigation into collaborative communication
and race was identified, it was found that this type of communication was less common
for Hispanic than for non-Hispanic white girls, p<.05 (Moss, Gilkey, Rimer, & et al,
2016). In regard to the attitudes toward HPV vaccination, Hispanic (versus White)
parents placed greater importance on HPV vaccination to benefit their son’s future sex
partners (b = .38). Black (b = .64) and Hispanic (b = .67; versus White) males reported
higher individualistic vaccination importance (Polonnijo, Carpiano, Reiter, & Brewer,
2016). Henry, et al mentioned that HPV initiation was higher among girls predominately
Hispanic areas, 69.0% vs. 49.9%; AOR, 1.64; 95% CI [1.43–1.87] or non-Hispanic
mixed race 60.4% vs. 49.9%; AOR, 1.30, 95% CI [1.17–1.44] compared with
predominately non-Hispanic white areas (Henry, Stroup, Warner, & Kepka, 2016).
Further research looks at targeting those considered to be high risk for HPV-related
cancers within underserved populations (Head, Biederman, Sturm, & Zimet, 2018).
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Studies on HPV Vaccination and Geographical Location
Regional disparities and variations in the United States are a significant barrier
and can have an effect on HPV vaccination uptake amongst adolescents. Additionally,
adolescent girls residing in the South were less likely to initiate the HPV vaccine then
adolescent girls residing in the Northeast. As a whole, the study showed that adolescents
from the northeastern regions of the United States were 1.62 times more likely to get
vaccinated then adolescents in southern regions of the United States, p = 0.000, OR 1.62,
95% CI [1.38, 1.90] (Sriram & Ranganathan, 2019). Lastly, collaborative communication
and geographical location were investigated to determine an effect. A study showed a
statistically significant effect when comparing the Northeast and the Southern
geographical location in regards to collaborative communication, it was found that
parents were more likely to report collaborative communication if they did not reside in
the South, OR 1.38, 95% CI [1.06, 1.81] (Moss, Gilkey, Rimer, & et al, 2016). Henry, &
et al mentioned that there was a significant difference in HPV initiation among girls in
high poverty communities compared with girls in low poverty communities 61.1% vs.
52.4%, AOR, 1.18; 95% CI [1.04–1.33] (Henry, Stroup, Warner, & Kepka, 2016).
Conclusion
Previous research has found a wealth of information regarding barriers to
vaccination. Provider recommendation is positively correlated with parent’s willingness
to increase HPV vaccination approval. Race and geographical location was also found to
have a significant effect on HPV vaccination uptake amongst adolescents in the United
States. Further research is needed to identify the strategies and areas that are beneficial in
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HPV uptake. In order to complete the aforementioned, it was important to identify the
areas that show significance.
Identifying provider types that are more successful in vaccinating against HPV in
geographical locations and races that are thriving will provide the most valuable
information. This study endeavored to contribute to the field of public health by
identifying the provider-types, regions and races with the most success in HPV
vaccination, so that we can identify a target audience to learn from and reciprocate the
educate to others within the field. This will enable a more effective vaccination strategy
and intervention, and an increase in vaccination across all, races, geographical locations,
and provider types. This will also result in the prevention of cancer, and the saving of
lives.
In Chapter 3, I will discuss my research design, planned methodology, population,
sampling and sampling procedures, data collection, and threats to validity.
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Chapter 3: Research Method
Introduction
In Chapters 1 and 2, details surrounding HPV vaccination, the vaccination
recommendations for HPV, and the purpose and rationale for this research study were
discussed. As mentioned previously, the purpose of this quantitative study was to
determine if certain races and provider-locations in specific regions of the United States
have better HPV vaccine uptake in adolescents, taking into account the importance of
determining specific racial and relational factors that may lead to a higher HPV
vaccination rate for possible further research on increased HPV uptake strategies.
Determining these factors can identify what strategies have the potential to aid in an
increase in HPV vaccination uptake, which will ultimately lead to addressing barriers that
may exist and a decrease in HPV infection. In Chapter 2, the literature review discussed
the known barriers of HPV vaccination and the possible implications for the low
vaccination rate; additionally, I discussed the gap in literature and detailed the current
literature on the topic. In this chapter, I discuss research design and the rationale for using
a quantitative methodology. I also detail the target population, data collection and data
analysis procedures, instrumentation, and threats to validity.
Research Design and Rationale
The overall purpose of this study was to examine the factors of race, providerlocation type, and region of the United States, and whether there is a significant effect on
HPV vaccine uptake among adolescents. I used a cross-sectional research design, as the
results of this study provided a glimpse into the probable outcome, and the characteristics
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and factors associated with it at a specific point in time (Sacred Heart University Library,
n.d.).
The results acquired from this study can be used to inform public health and
health promotion strategies to increase HPV vaccination uptake amongst adolescents. In
this study, I used a quantitative methodology and conducted a binary logistic regression
analysis to determine the effect of race, provider-location type, and region of the United
States, on HPV vaccine uptake among adolescents. This type of analysis will help to
determine statistical significance amongst these factors in a cohesive manner. Secondary
data from the National Immunization Survey (NIS) was used to address the research
questions. From this survey, I retrieved the HPV data for adolescents, as well as data on
the targeted demographics of said adolescents. There were no time and resource
constraints with this design choice.
Methodology
Population
The target population for this study consisted of adolescents between the ages of
13 and 17 living in the United States at the time of the survey in year, 2018. The target
population also consisted of adolescents across the United States in this age group, who
have received one or more doses of HPV vaccination. The NIS data has a sample size of
approximately 38,706. According to CDC, sample estimates and actual population values
may differ; however, the difference is quantified through the 95% confidence interval and
therefore still representative of the adolescent population in the United States (Centers for
Disease Control and Prevention, 2015).

26

Data Collection
The secondary data source for this study was the NIS. The NIS conducted the first
survey in April 1994 (Centers for Disease Control and Prevention, 2018). NIS data is
retrieved via telephone interviews with parents or guardians in all 50 states, the District
of Columbia, and some U.S. territories (Centers for Disease Control and Prevention,
2018). The process of selection begins with cell phone numbers being randomly selected
and called to enroll age-eligible teens from the household (Centers for Disease Control
and Prevention, 2018). Names of participants’ children’s vaccination providers are
requested along with permission to contact them; this is needed in order to confirm the
vaccination information provided by the parent (Centers for Disease Control and
Prevention, 2018). Once permission is obtained from the parent, a questionnaire is mailed
to each child’s vaccination provider(s) to collect vaccine information regarding the
number of doses and dates of vaccine administration (Centers for Disease Control and
Prevention, 2018). Inclusion criteria for the NIS applied to parents of students between
the ages of 13-17 who participated in the survey. Exclusion criteria was applied to
parents of students who did not participate in the study.
The NIS survey was selected for this study because it is inclusive of the target
population and adolescent vaccines, specifically HPV vaccination. Through the use of the
NIS I obtained current, population-based, state estimates of HPV vaccination coverage
(Centers for Disease Control and Prevention, 2018). The NIS is conducted by the Centers
for Disease Control and Prevention, which shows the reliability and validity of this data
source. The NIS data is publicly available on the CDC’s website at
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https://www.cdc.gov/vaccines/imz-managers/nis/data-tables.html; no formal permission
was required to use or access this data.
Sampling Procedures
The NIS sample is representative of the adolescent population in the United
States. As mentioned previously, the sample size for the NIS is approximately 38,706.
Determining the appropriate sample size was important to ensure a valid sample and
statistical significance. Using the Raosoft calculator the recommended sample size
produced is 381, with a margin of error of 5%, a confidence level of 95%, a population
size of 38,706 and a response rate of 50% (Raosoft, 2004).
Instruments
As mentioned previously, the instrument that was used for this study is the 2018
NIS. The survey is administered to parents of adolescents across the United States, in
reference to several vaccines including HPV vaccination; approximately four questions
will be analyzed.
Operationalization
The effects of the following factors were analyzed:
Race, which is an independent variable, is defined as one of the following: White, Black
or African American, American Indian, Alaska Native, Asian, Native Hawaiian or other
Pacific Islander. Provider-location type, which is an independent variable that is defined
as the location of the vaccine provider. Region of the United States, which is also an
independent variable in this study and is defined as West, Midwest, Northeast, and South.
The aforementioned variables were used to determine the effect on the dependent
variable of HPV vaccination rates amongst adolescents, which includes 13-17-year old’s.
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The survey questions used provided the demographic information, such as race, at which
provider-location the HPV vaccination was received, and the state in which the
adolescent received the HPV vaccine. Questions from the NIS that were used for this
study can be found in Appendix A. Variables and questions used form the NIS are listed
in Table 2 below.
Table 2
NIS Teen Data Variables and Questions
Variable Name

Variable type

Statistical test

Question

TIS_BHPV2

Dependent variable

Binary regression

Has [TEEN] ever
received HPV shots?

TIS_BHPV_LOCATIO
N

Independent variable

Binary regression

Please tell me all the
types of places
where [TEEN] has
received an HPV
shot. READ IF
NECESSARY: This
question is referring
to the location of the
vaccine provider, not
to the location on the
body where the shot
was given.

TIS_C4

Independent variable

Binary regression

Now, I am going to
read a list of
categories. Please
choose one or more
of the following
categories to
describe [TEEN]’s
race. Is [TEEN]
White, Black or
African American,
American Indian,
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Alaska Native,
Asian, Native
Hawaiian or other
Pacific Islander?

TIS_C19

Independent variable

Binary regression

In what city, county
and state do you
live?

Data Analysis Plan
The Statistical Package for the Social Sciences (SPSS) was used to conduct the
data analysis. Questions that were not relevant were removed from the data sample;
coding identifiers were available.
Research Questions
A qualitative research methodology was considered however, it would be very
difficult to capture attitudes and beliefs associated with HPV rates amongst adolescents
across the country. Therefore, the quantitative methodology was the preferred
methodology for this study. As mentioned previously, using a quantitative research
approach, I looked to address the following research questions:
Research Question 1: What is the effect of race and region of the United States,
on HPV vaccine uptake in adolescents?
The dependent variable in this research question is HPV uptake in adolescents,
while the independent variables are race and region of the United States. The statistical
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test that will be used for this research question is a binary logistic regression analysis to
determine if there is an effect.
Research Question 2: What is the effect of race and provider-location type on
HPV vaccine uptake in adolescents?
The dependent variable in this research question is HPV vaccine uptake in
adolescents, the independent variables are race and provider-location type. The statistical
test that will be used for this research question is a binary logistic regression analysis to
determine if there is an effect.
Research Question 3: What is the effect of region of the United States and
provider-location type, on HPV vaccine uptake in adolescents?
The dependent variable in this research question is HPV vaccine uptake in
adolescents, and the independent variables are region of the United States and providerlocation type. The statistical test that will be used for this research question is a binary
logistic analysis to determine if there is an effect.
Research Question 4: Does race modify the effect of region of the United States,
on HPV vaccine uptake in adolescents?
The dependent variable in this research question is HPV vaccine uptake in
adolescents, and the independent variables are race and region of the United States. The
statistical test that was used for this research question is a binary logistic regression
analysis which aimed to determine am estimate of an effect of region of the United States
while adjusting for race in HPV vaccine uptake in adolescents.
Research Hypotheses
The hypotheses for this study consisted of the following;
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H01: There is no effect of race and region of the United States, on HPV vaccine
uptake in adolescents.
H0a: There is a significant effect of race and region of the United States, on HPV
vaccine uptake in adolescents.
H01: There is no effect of race and provider-location type, on HPV vaccine uptake
in adolescents.
H0a: There is a significant effect of race and provider-location type, on HPV
vaccine uptake in adolescents.
H01: There is no effect of region of the United States and provider-location type,
on HPV vaccine uptake in adolescents.
H0a: There is a significant effect of region of the United States and providerlocation type, on HPV vaccine uptake in adolescents.
H01: Race does not modify the effect of region of the United States, on HPV
vaccine uptake in adolescents.
H0a: Race significantly modifies the effect of region of the United States, on HPV
vaccine uptake in adolescents.
In order to address the aforementioned research questions, a combination of
various statistical approaches were used. Descriptive statistics, and p-value was used to
determine association, a binary logistic regression was used to determine if there is a
statistically significant effect and a Pearson chi-square test was used to determine
whether a relationship between the variables existed. As mentioned previously, a binary
logistic regression was used to predict the value of a variable, in this case the dependent
variable, which is HPV vaccination amongst adolescents, based on the value of two or
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more other variables, in this case, the independent variables, which are race, providerlocation type and region of the United States (Laerd Statistics, 2018). The significance
level was set at 0.05 with a 95% confidence interval. Covariates were not included in this
data analysis.
Threats to Validity
A discussion of both internal and external validity was very important to assess
the validity of the results presented in a study. Threats to external validity are any factors
within a study that reduce the generalizability of the results (Laerd Statistics, 2012a). The
threats to internal validity are factors that can affect the outcome (Laerd Statistics,
2012b). Quantitative research designs can make outcomes and generalizations from
the sample being studied. The outcomes and generalizations include the population in
which the sample is drawn, and/or across populations (Laerd Statistics, 2012a).
Selection biases is an example of threats to internal and external validity. The NIS
sample used can have selection/volunteer bias as the individuals sampled may be from
parents who only use cell phones, and not parents who have landlines. The
aforementioned example can be a threat to validity as this group of parents may not be
random enough to be representative of the population. An additional, example of
selection bias is the age of the sample may be disproportionate, the response rate for older
parents with adolescent children may be different from younger parents with adolescent
children, causing a threat to validity as this may cause the result to be invalidated as not
representative of the population.
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The threats to construct validity were also important to address as this aspect
focused on the generalizability from my study and whether it actually measured HPV
uptake amongst adolescents (Trochim, 2020).
Ethical Procedures
Ethical considerations were made with the use of secondary data, as this data was
publicly available, and permissions are not required. In regard to confidentiality, the data
was aggregated, and no identifying information was available. The data file was stored in
SPSS on my computer until the approval of dissertation, IRB approval of storage policy
was confirmed. Participation in the survey was voluntary and participants were made
aware of their choice, verbal consent was given.
Summary
In Chapter 3, I detailed the research design and rationale of this study, along with
the methodology to include the target population. I also detailed the sampling and
sampling procedures, the dataset to be used, instrumentation and operationalization of the
data, threats to validity and ethical procedures. In Chapter 4, I will discuss the data
analysis and detail the results of the analyses.
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Chapter 4: Results
Introduction
The purpose of this quantitative study was to determine if there is an effect of race,
provider-location type, and region on HPV vaccine uptake amongst adolescents. The predictor
variables included race, provider-location type, and geographical/census region, while the
dependent variable is HPV uptake amongst adolescents. This study examined whether there is a
significant effect between the predictor variables and the dependent variable. The results
determined areas where HPV vaccination in adolescence is increasing and areas in which HPV
vaccination is lagging. Data for this study were acquired from the 2018 NIS-Teen survey to
answer my research questions; the data were analyzed using SPSS version 25. In this chapter, I
discuss the data collection methods, detail the research questions and hypotheses, discuss the
statistical assumptions, and relay the results of the study.
Discrepancies
I intended to use a multiple regression analysis to answer my research questions.
However, it was determined that the best fit for this study would be the use of a binary logistic
regression, as my dependent variable is dichotomous. Additionally, in reference to the providerlocation type variable, there were a total of 20,139 (52%) missing variables, however, the power
analysis deemed the amount of responses received were sufficient for this study.
Dependent Variable
The dependent variable in this study included receipt of HPV vaccination. This
variable was ascertained by asking respondents if their adolescent child had received an
HPV vaccine. The dependent variable was recoded in SPSS as ‘No HPV shot’ and ‘Yes
HPV shot.’
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Independent Variables
The independent variables included race, which used the categories of White only, Black
only, and Other/multiple races. Another independent variable was geographical/census region,
which used the categories of Northeast, Midwest, South and West. The independent variable of
provider-location type used the categories of all public facilities, all private facilities, all hospital
facilities, all STD/School/Teen clinic, mixed, unknown, and missing.
Research Questions and Hypotheses
The research questions and hypotheses for this study included the following:
RQ1: What is effect of race and region of the United States, on HPV vaccine uptake in
adolescents?
H01: There is no statistically significant effect of race and region of the United
States, on HPV vaccine uptake in adolescents.
H0a: There is a statistically significant effect between race and region of the
United States, on HPV vaccine uptake in adolescents.
RQ2: What is the effect of race and provider-location type on HPV vaccine uptake in
adolescents?
H02: There is no statistically significant effect of race and provider-location type,
on HPV vaccine uptake in adolescents.
H0a: There is a statistically significant effect of race and provider-location type,
on HPV vaccine uptake in adolescents.
RQ3: What is the effect of region of the United States and provider-location type on HPV
vaccine uptake in adolescents?
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H03: There is no statistically significant effect of region of the United States and
provider-location type on HPV vaccine uptake in adolescents.
H0a: There is a statistically significant effect of region of the United States and
provider-location type on HPV vaccine uptake in adolescents.
RQ4: Does race modify the relationship of region of the United States on HPV vaccine
uptake in adolescents?
H04: Race does not modify the relationship of region of the United States on HPV
vaccine uptake in adolescents.
H0a: Race significantly modifies the relationship of region of the United States on
HPV vaccine uptake in adolescents.
Data Collection
The secondary data source for this study was the 2018 NIS. The NIS survey was
selected for this study because it is inclusive of the target population and adolescent
vaccines, specifically HPV vaccination. Through the usage of the NIS, I obtained current,
population-based state estimates of HPV vaccination coverage (Centers for Disease
Control and Prevention, 2018). Data from the NIS is retrieved through telephone
interviews with parents or guardians in all 50 states, the District of Columbia, and some
U.S. territories (CDC, 2018). The cell phone numbers are randomly selected and the
parents and guardians of eligible children are asked for the names of their children’s
vaccination providers and permission to follow-up with them to verify information
provided. Once the survey is completed, a questionnaire is mailed to each child’s
vaccination provider(s) to collect the information on vaccination type, dose number, dates
of administration, and other additional administrative data about the health care facility
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(CDC, 2018). The NIS is conducted by the Centers for Disease Control and Prevention,
which shows the reliability and validity of this data source.
Results
This section details descriptive statistics, results of the chi-square test, and results of the
binary logistic regression analyses.
Descriptive Statistics
A summary of the descriptive statistics can be found in Tables 3 through 9. The
participants’ age range is 13 to 17 years and the sample size is n = 38,706. The survey’s
respondents were primarily of White race adolescents, of which accounted for 29,531 (76.3%) of
the study population; Black adolescents accounted for 3,975 (10.3%), and other/multiple race
adolescents accounted for 5,200 (13.4%) of the study population. Of the census regions, 7,096
(18.3%) of respondents were from the Northeast region, 8,194 (21.2%) were from the Midwest
region, 15,382 (39.7%) were from the South, and 8,034 (20.8%) of the study population were
from the West. Amongst the provider-location types, 2,399 (6.2%) reported All Public, 2,012
(5.2%) reported All Hospital, 8,080 (20.9%) reported All Private, 490 (1.3%) reported All
STD/Teen/School, 3,330 (8.5%) reported mixed, 2,286 (5.9%) reported unknown, and 20,139
(52.0%) were missing. Table 6 shows HPV uptake amongst adolescents responses received from
survey responders. Of the survey responders, 14,084 (40.3%) reported No HPV shot and 20,896
(59.7%) responded Yes HPV shot. This sample size is appropriate and proportionate to the larger
population, as the Raosoft calculator recommended a sample size of 381 and a population size of
38,706.
Table 7 shows the crosstabulation of race and HPV vaccination uptake. The results show
that Black race adolescents (61.8%) were more likely than White race adolescents (59.4%) and
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other/multiple race adolescents (60.3%) to receive an HPV vaccine. Table 8 shows the
crosstabulation of census region. The results show that adolescents living in the Northeast region
(66.1%) were more likely than adolescents in the South (57.7%), Midwest (60.7%), and West
(57.1%) to receive an HPV vaccination. Table 9 shows the crosstabulation of provider-location
type, and the results show that adolescents seeking care at hospitals (70.3%), and private
facilities (66.4%) were more likely than public (59.4%), STD/School/Teen clinic (59.1%), and
mixed facilities (65.8%) to receive an HPV vaccine.
Table 3
Race
Variable
Race
White only
Black only
Other/multiple
Total

N
29,531
3,975
5,200
38,706

Valid %

Cumulative %

76.3
10.3
13.4
100

76.3
86.6
100

Table 4
Region
N

Variable
Census region
Northeast
Midwest
South
West
Total

7096
8194
15382
8034
38,706

Valid %
18.3
21.2
39.7
20.8
100

Cumulative %
18.3
39.5
79.2
100

Table 5
Provider-Location Type

Variable

N

Percent

Valid %

Cumulative %

39

Provider location
type
All public
facilities
All hospital
facilities
All private
facilities
All STD/school
/teen clinics
Mixed
Unknown
Missing
Total

2399

6.2

12.9

12.9

2012

5.2

10.8

23.8

8080

20.9

43.5

67.3

490

1.3

2.6

69.9

3300

8.5

17.8

87.7

2286

5.9

12.3

100

20139

52.0

38,706

100

100

Table 6
HPV Vaccination Uptake

No HPV
Shot
Yes HPV
Shot
Total

Frequency
14084

%
36.4

Valid %
40.3

Cumulative %
40.3

20896

54.0

59.7

100.0

34980

90.4

100

Table 7
Crosstabulation of Race and HPV Vaccination Uptake
Variable

Category

Race

White only
% within race
% within HPV
uptake
% of total

HPV vaccine uptake
No HPV shot
Yes HPV shot
10931
15976
40.6%
59.4%
77.6%
76.5%

Total

31.2%

76.9%

45.7%

26907
100%
76.9%
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Black only
% within race
% within HPV
uptake
% of total
other + multiple
% within race
% within HPV
uptake
% of total
Total
% within race
% with HPV
uptake
% of total

1345
38.2%
9.5%

2175
61.8%
10.4%

3520
100%
10.1%

3.8%
1808
39.7%
12.8%

6.2%
2745
60.3%
13.1%

10.1%
4553
100%
13.0%

5.2%
14084
40.3%
100%

7.8%
20896
59.7%
100%

13.0%
34980
100%
100%

40.3%

59.7%

100%

Table 8
Crosstabulation of Region and HPV Vaccination Uptake
Variable

Category

Region

Northeast
% within region
% within HPV
Uptake
% of Total
Midwest
% within region
% within HPV
Uptake
% of Total
South
% within region
% within HPV
Uptake
% of Total
West
% within region
% within HPV
Uptake
% of Total

Total
% within region
% within HPV
Uptake

HPV vaccine uptake
No HPV shot
Yes HPV shot
2164
4214
33.9%
66.1%
15.4%
20.2%

Total

6.2%
2952
39.3%
21.0%

12.0%
4550
60.7%
21.8%

18.2%
7502
100%
21.4%

8.4%
5869
42.3%
41.7%

13.0%
8013
57.7%
38.3%

21.4%
13882
100%
39.7%

16.8%
3099
42.9%
22.0%

22.9%
4119
57.1%
19.7%

39.7%
7218
100%
20.6%

8.9%
14084
40.3%
100%

11.8%
20896
59.7%
100%

20.6%
34980
100%
100%

6378
100%
18.2%
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% of Total

40.3%

59.7%

100%

Table 9
Crosstabulation of Provider-Location Type and HPV Vaccination Uptake
Variable

Category

Provider Location All Public
Facilities
% within Provider
Location
% within HPV
Uptake
% of Total
All Hospital
Facilities
% within Provider
Location
% within HPV
Uptake
% of Total
All Private
Facilities
% within Provider
Location
% within HPV
Uptake
% of Total
All STD/School/
Teen Clinics
% within Provider
Location
% within HPV
Uptake
% of Total
Mixed
% within Provider
Location
% within HPV
Uptake
% of Total
Unknown
% within Provider
Location

HPV Vaccine Uptake
No HPV shot
Yes HPV shot
847
1241

Total

40.6%

59.4%

100%

14.4%

11.1%

12.3%

5.0%
558

7.3%
1320

12.3%
1878

29.7%

70.3%

100%

9.5%

11.8%

11.0%

3.3%
2503

7.7%
4939

11.0%
7442

33.6%

66.4%

100%

42.6%

44.3%

43.7%

14.7%
179

29.0%
259

43.7%
438

40.9%

59.1%

100%

3.0%

2.3%

2.6%

1.1%
1055
34.2%

1.5%
2028
65.8%

2.6%
3083
100%

17.9%

18.2%

18.1%

6.2%
738
35.0%

11.9%
1373
65.0%

18.1%
2111
100%

2088

42

% within HPV
Uptake
% of Total
Total

12.6%

12.3%

12.4%

4.3%
5880
% within Provider 34.5%
Location
% within HPV
100%
Uptake
% of Total
34.5%

8.1%
11160
65.5%

12.4%
17040
100%

100%

100%

65.5%

100%

Statistical Assumptions: Pearson Chi-Square Test
Statistical assumptions should be met when conducting a chi-square test. The first
assumption is that two variables should be measured at an ordinal or nominal level, this
assumption was met in this study as the independent variables of race, region, and providerlocation type are each, categorical (Laerd Statistics, 2018). The next assumption is that the
variables should consist of two or more categorical, independent groups, this assumption was
met in this study as race has three independent groups, census region has four independent
groups, and provider-location type has six independent groups (Laerd Statistics, 2018).
Statistical Assumptions: Binary Logistic Regression
Statistical assumptions are to be met when conducting the binary logistic regression. The
first assumption indicated that the dependent variable should be measured on a dichotomous
scale, this was met as the dependent variable HPV vaccine received is a dichotomous variable
with answers of either yes or no. The second assumption indicated that there are one or more
independent variables that are either continuous or categorical, this assumption has been met as
the independent variables of race, census region, and provider-location type are each considered
categorical (Laerd Statistics, 2018). The third assumption indicated there should be
independence of observations and the dependent variable should have mutually exclusive and
exhaustive categories, this assumption was met as the variables whether dependent or
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independent were mutually exclusive (Laerd Statistics, 2018). The fourth assumption indicated
that there needs to be a linear relationship between any continuous variable, of which is not
applicable in this study as the independent variables were categorical (Laerd Statistics, 2018). It
was verified that the binary logistic regression assumptions have been met.
Binary Logistic Regression Analysis
A binary logistic regression analysis was conducted to examine the effect of race, and
region on HPV vaccine uptake amongst adolescents; race, and provider-location type on HPV
vaccine uptake amongst adolescents; region and provider-location type on HPV vaccine uptake
amongst adolescents and the interaction of race and region on HPV vaccine uptake in
adolescents. The binary logistic regression was selected for this study because I will be using 3
independent variables and a dichotomous dependent variable. Table 10 shows how many cases
were included in the analyses, how many cases were excluded or missing and how many cases
were in total. There were a total of 38,706 total cases, 34,980 were included in the analysis and
3,726 were missing. Additionally, the results of the chi-square analysis showed statistical
significance. The model, containing each of the predictor variables, resulted in X2(11, n =
38,706) = 165.4, p < .001. All predictors provided a unique statistically significant contribution
to the model (see Table 11).
Table 10
Case Summary
Selected Cases
Included in Analysis
Missing Cases
Total
Unselected Cases

N

%

34,980
3,726
38,706
0

90.4
9.6
100
0
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Table 11
Chi-square Test
Chi-square
165.399

Model

Df
11

p
.000

Statistical Analysis Findings
Research Question 1 (RQ1): What is effect of race and region of the United States, on HPV
vaccine uptake in adolescents?
To address RQ1, a binary logistic regression and chi-square test was conducted to
determine whether there was an effect of race and region of the United States, on HPV vaccine
uptake amongst adolescents and whether there was a relationship between the variables. The chisquare test containing the race and census region predictor variables, was significant overall,
X2(5, n = 38,706) = 164.951, p < .000. Although, the model was significant, Black race (p=.113),
other/multi race (p=.282), and the Western region (p=.509), did not have a significant effect on
HPV uptake amongst adolescents. As shown in Table 12, both predictors provided unique
statistically significant contributions to the model. Specifically, White race adolescents were
shown to be significant (p=.010), as well as the Northeast (p=.000), Midwest (p=.000), and the
Southern (p=.000) regions each of which were shown to be significant. Additionally, the model
explained .006 (Nagelkerke R2) of the variance of HPV vaccination and correctly classified
59.7% of cases.
In this model, the odds ratio for other/multiple race adolescents were 1.05 times those of
White race adolescents to receive an HPV vaccine, however, this difference was also not
statistically significant. Also, in this model, adolescents living in the Midwest were 1.5 times
those of adolescents living in the Northeast to have received an HPV vaccine. Also, adolescents

45

in the South were 1.2 times those of adolescents living in the Northeast to have received an HPV
vaccine. The Western region was shown not have a significant effect in comparison to the
Northeast region (see Table 12).
Table 12
Binary Logistic Regression: Race and Census Region

B

S.E.

-.052
.050

.033
.047

Race1
Black
Other/
Multiple

Wald
9.154
2.511
1.157

df
2
1
1

P
.010
.113
.282

95% C.I. for Odds Ratio
Odds Ratio
.949
1.052

.890
.960

1.012
1.152

1.361
1.086
.962

1.566
1.239
1.081

Region2

154.049 3
.000
.378
.036
112.027 1
.000
1.460
.148
.034
19.395
1
.000
1.160
.020
.030
.436
1
.509
1.020
Constant
.323
.036
82.588
1
.000
1.382
Note. 1 - White only is the reference group; 2 – Northeast is the reference group
Midwest
South
West

Research Question 2 (RQ2): What is the effect of race and provider-location type on HPV
vaccine uptake in adolescents?
To address RQ2, a binary logistic regression was conducted to determine whether there
was an effect of race and provider-location type on HPV vaccine uptake in adolescents. The chisquare model, containing the race and provider-location type, predictor variables, was
significant, X2(7, n = 38,706) = 85.72, p < .000. Although, the model was statistically significant,
other/multiple race adolescents (p=.305), and all STD/School/Teen clinic (p=.181) did not have a
statistically significant impact on the effect of HPV vaccine uptake amongst adolescents. As
shown in Table 13, various predictors provided a unique statistically significant contribution to
the model. Specifically, the White race (p=.000), and Black race (p=.002) are shown to be
significant. All public facilities (p=.000), All hospital facilities (p=.000), all private facilities
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(.000), and a Mixture of facilities (p=.021) were statistically significant with a p<.05. The model
explained .007 (Nagelkerke R2) of the variance of HPV vaccination and correctly classified
65.5% of cases. Table 13 depicts the binary regression summary.
In this model, the results show that Black race adolescents were 0.86 times less likely
than White race adolescents to receive an HPV vaccine. Additionally, other/multiple race
adolescents were 1.1 times those of White race adolescents to receive an HPV vaccine, however,
this difference was not statistically significant (see Table 13). The results also show that all
hospital providers were 0.78 times less likely than those at all public facilities to have received
an HPV vaccine. All private facilities were 1.3 times those of all public facilities to have
received an HPV vaccine. Moreover, all STD/school/teen clinics were 1.1 times those of all
public facilities to have received an HPV vaccine, however, this difference was deemed not
statistically significant. Lastly, mixed facilities only .78 times less likely than those of all public
facilities to have received an HPV vaccine.
Table 13
Binary Logistic Regression: Race and Provider-Location Type
95% C.I. for Odds Ratio
B

S.E.

Wald
22.253
9.852
1.054

df
2
1
1

p
.000
.002
.305

67.180

5

.000

-.245 .064

14.747

1

.246

.068

13.032

.069

.052

-.247 .107
.042 .059

Race1
Black only
Other/
Multiple

-.155 .049
.075 .073

Provider
Location2
All Hospital
Facilities
All Private
Facilities
All STD/School/
Teen Clinics
Mixed
Unknown

Odds Ratio
.857
1.077

.778
.934

.944
1.242

.000

.782

.690

.887

1

.000

1.279

1.119

1.462

1.786

1

.181

1.072

.968

1.187

5.293
.490

1
1

.021
.484

.781
1.043

.633
.928

.964
1.171
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Constant

.730

.063

136.120

1

.000

2.076

Note. 1 - White only is the reference group; 2 – All Public Facilities is the reference group

Research Question 3 (RQ3): What is the effect of region of the United States and
provider-location type, on HPV vaccine uptake in adolescents?
To address RQ3, a binary logistic regression was conducted to determine whether there
was an effect of region of the United States and provider-location type on HPV vaccine uptake in
adolescents. The model, containing the region and provider-location type, predictor variables,
was significant, X2(8, n = 38,706) = 130.016, p < .000. As mentioned previously, the model was
statistically significant, however, the Southern region (p=.129), the Western region (p=.779), All
STD/School/Teen Clinic (p=.409), and a mixture of clinics (p=.458) did not have a statistically
significant impact on the effect of HPV vaccination amongst adolescents. As shown in Table 14,
both predictors provided unique statistically significant contributions to the model. Specifically,
the Northeast region (p=.000), and the Midwest region (p=.000) is shown to be significant. All
public facilities (p=.000), All hospital facilities (p=.000), and All private facilities (p=.003) are
shown to be significant. The model explained .010 (Nagelkerke R2) of the variance of HPV
vaccination and correctly classified 65.5% of cases. Table 14 depicts the binary regression
summary.
In this model, the results show that adolescents residing in the Midwest were 1.4 times
those adolescents residing in the Northeast to receive an HPV vaccine. Additionally, adolescents
residing in the South were 1.1 times those of adolescents residing in the Northeast to receive an
HPV vaccine, however, this difference was not statistically significant (see Table 14).
Table 14 also shows that adolescents who seek healthcare in all hospital facilities were
only .80 times those at all public facilities to have received an HPV vaccine. Also, adolescents at
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private facilities were 1.2 times those at all public facilities to have received an HPV vaccine.
Adolescents who attend all STD/school/teen clinics were 1.0 times those at all public facilities to
have received an HPV vaccine, however, this difference was not deemed to be statistically
significant. Lastly, adolescents that attend mixed facilities are 1.1 times those at all public
facilities to have received an HPV vaccine, however the difference was also not deemed to be
statistically significant.
Table 14
Binary Logistic Regression: Census Region and Provider-Location Type

B

S.E.

Region1

Wald

df

P

95% C.I. for Odds Ratio
Odds Ratio

Midwest
South
West

.356 0.53
.074 .049
-.012 .043

65.082
44.701
2.299
.079
51.176

3
1
1
1
5

.000
.000
.129
.779
.000

1.428
1.077
.988

1.286
.978
.907

1.585
1.186
1.075

All Hospital
Facilities
All Private
Facilities
All STD/
School/Teen
Clinics
Mixed

-.229 .064

12.866

1

.000

.795

.701

.901

.201 .069

8.582

1

.003

1.222

1.069

1.398

.043 .052

.681

1

.409

1.044

.943

1.156

.0444 .060

.550

1

.458

1.045

.930

1.174

Provider
Location2

Constant
Note. 1 - Northeast is the reference group; 2 – All Public Facilities is the reference group

Research Question 4 (RQ4): Does race modify the relationship of region of the United
States, on HPV vaccine uptake in adolescents?
To address RQ4, a binary logistic regression was conducted to determine the
significance of the interaction between race and region on HPV vaccine uptake amongst
adolescents. The model, containing the race and region interaction, predictor variables, was
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significant, X2(1, n = 38,706) = 13.851, p < .000. The model containing the interaction shows
that the interaction between race and region was also statistically significant with a (p=.000)
(See Table 15). The model explained .001 (Nagelkerke R2) of the variance of HPV
vaccination and correctly classified 59.7% of cases.
Table 15
Binary Logistic Regression: Race x Region
95% C.I. for Odds Ratio
B
Race by Region -.016
Constant
.453

S.E.
.004
.019

Wald
13.900
564.940

Df
1
1

p
.000
.000

Odds Ratio
.984
1.572

.976

.992

Summary
In this chapter, NIS-teen data was used to determine the effect of race, provider-location
type, and region on HPV vaccination uptake among adolescents. The data has been identified
and analyzed to answer the research questions presented in this study. The sample size of the
data was 38,706, missing data was removed from the recoded HPV vaccination receipt, of which
34,980 were included in the analysis.
As a result of the findings, the chi-square test conducted shows that race and region had
a statistically significant effect on HPV vaccination uptake among adolescents. The chi-square
test also shows that race and provider-location type had a statistically significant effect on HPV
vaccination uptake amongst adolescents. Additionally, region and provider-location type results
from the chi-square test showed a statistically significant effect on HPV vaccination uptake
amongst adolescents. The interaction between race and region was also found to be statistically
significant based on the results of the chi-square test.
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The binary logistic regression analysis conducted for RQ1 showed statistical
significance amongst adolescents of White race, and adolescents residing in the Northeast,
Midwest, and South. The binary logistic regression analysis conducted for RQ2 showed
statistical significance amongst adolescents of White race and Black race, and adolescents
who acquired HPV vaccination at public facilities, hospital facilities, private facilities and
mixed facilities. The binary logistic regression analysis conducted for RQ3 showed statistical
significance amongst adolescents in the Northeast, Midwest, who accessed services at all
public facilities, all hospital facilities, and all private facilities. Lastly, the binary logistic
regression analysis conducted for RQ4 showed statistical significance with the interaction of
race and region on HPV vaccination uptake amongst adolescents.
As a result of the analysis, the null hypothesis that there is no statistically significant
effect of race and region of the United States on HPV vaccine uptake in adolescents was
rejected and the alternative hypothesis was accepted. Additionally, the null hypothesis stating
that there is no statistically significant effect of race and provider-location type on HPV vaccine
uptake in adolescents was rejected and the alternative hypotheses was accepted. The null
hypothesis that indicates that there is no statistically significant effect of region of the United
States and provider-location type on HPV vaccine uptake in adolescents was also rejected and
the alternative hypothesis was accepted. Lastly, the null hypothesis that indicated race does not
modify the relationship of region of the United States, on HPV vaccine uptake in adolescents
was also rejected, and the alternative hypothesis was accepted.
In Chapter 4 the results of the study were presented, in Chapter 5, I will detail the
overall interpretation of the findings, the limitations of the study, recommendations, and
implications.
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Chapter 5: Discussion
Introduction
The purpose of this quantitative study was to determine if there was an effect of
race, provider-location type, and region of the United States on HPV vaccine uptake
amongst adolescents. Research conducted previously looked into communication factors,
such as provider recommendation and its positive correlation of HPV vaccination
willingness. However, there is limited research on specific factors that may affect HPV
vaccine uptake in adolescents, hence the reasoning for this study. This study used 2018
NIS Teen data to answer the four research questions. The sample size of the survey
consisted of 38,706 respondents. The theoretical framework used for this study was the
Health Belief Model, which helped explain the importance of attitude and strategies that
can be used to increase the intent and uptake of HPV vaccination amongst adolescents. A
Pearson Chi-square test was used to analyze the significance of the model, and a binary
logistic regression was used to address each of the research questions.
Summary of Key Findings
There were several key findings from this study. Descriptive statistics were
conducted and found that survey respondents were primarily of White race (76.3%), were
primarily from the Southern region (39.7%) and seek healthcare at all private providers
(20.9%). It was determined that there was a statistically significant effect amongst each
of the independent variables, of which include race, provider-location type and region, on
the dependent variable of HPV vaccine uptake amongst adolescents. There was a
statistically significant effect amongst race and region on HPV vaccine uptake amongst
adolescents, with significant races and region having increased HPV vaccination uptake.
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There was also a statistically significant effect amongst race and provider-location
type. There was also a statistically significant effect among region and provider-location
type and amongst the interaction between race and region on HPV vaccination uptake
amongst adolescents. I will discuss the interpretation of the findings, limitations of the
study, recommendations, and implications of social change.
Interpretation of the Findings
HPV Vaccination and Race
Siriam and Ranganathan (2019) conducted a study that showed Hispanics were
1.47 times more likely than other races to receive HPV vaccination. Burdette et al. (2017)
also conducted a survey that showed that minority adolescent males had a higher rate of
HPV vaccine initiation and non-Hispanic whites had a lower HPV vaccine initiation.
Henry et al. (2016) conducted a study which resulted in higher HPV vaccination among
girls in predominately Hispanic areas: 60.4% compared with predominately White areas,
49.9%. According to this study, when analyzing the data for race and provider-location
type, White race adolescents and Black race adolescents were shown to be statistically
significant, while the other/multiple race adolescents was shown to not have a
statistically significant effect on HPV vaccination uptake amongst adolescents.
Additionally, when controlling for race and region, the White race was shown to be
statistically significant, while Black race and other/multiple race adolescents, showed to
not have a statistically significant effect on HPV vaccination uptake among adolescents.
This study shows that when assessing for different variables, there may also be a
difference in the effect. For instance, in this study White race was statistically significant
when assessed with provider-location type and region. This also shows the need for
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further research as to what strategies are working within the White race and Black race
adolescents that received HPV vaccination at public, hospital and private facilities and
what strategies are working in the White race adolescents in the Northeastern, Midwest,
and Southern regions.
HPV Vaccination and Geographical Region
Siriam and Ranganathan (2019) conducted a study that showed adolescent girls
residing in the South were less likely to initiate the HPV vaccine compared to adolescent
girls residing in the Northeast region. This study confirmed the findings, as the
Northeastern region had a significant effect on HPV vaccination rate as compared to
adolescents residing in the South when controlling for provider-location type. Moss et al.
(2016) also conducted a survey that found that parents were more likely to report
collaborative communication if they did not reside in South OR 1.38, 95%, CI [1.06,
1.81].
Within this study, when analyzing for region and provider-location type, the
Northeast region and Midwest region were shown to have a statistically significant effect
on HPV vaccination uptake amongst adolescents. It was also determined that when
analyzing for both region and race, the Northeast region, Midwest region and the
Southern region were shown to be significant. Both analyses showed a statistical
significance amongst the Northeast and Midwest region, therefore, determining the
strategies used within those regions, to implement in the states within the Southern and
Western regions to increase HPV vaccination amongst adolescents in these areas.
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HPV Vaccination and Provider-Location Type
Garbutt et al. (2018) conducted a study that determined that provider
recommendations in the primary care setting informs implementation strategies which
results in increased vaccination of HPV vaccine. Katz et al. (2016) determined that
further research should look into the strategies to support providers and collaboration at
the practice level (Katz, Bogart, Fu, & et al, 2016). Within this study, the analysis of race
and provider-location type resulted in statistical significance amongst all public facilities,
all hospital facilities, all private facilities, and mixed facilities. Additionally, the analysis
of region and provider-location type resulted in statistical significance amongst all public
facilities, all hospital facilities and all private facilities.
This study also shows specifically which provider-location types, cohesively
along with other predictor variables, including race and region, have a statistically
significant effect on HPV vaccination uptake amongst adolescents. This will allow
researchers to determine which provider-location types have an increased HPV
vaccination uptake amongst adolescents, which will ultimately assist underperforming
provider locations determine and implement strategies to increase HPV vaccination.
Theoretical Framework
The theoretical framework used in this study was the HBM. This study found
statistical significance among various cohesive factors, amongst race, region, and
provider-location type. The statistical significance results proven within this study,
amongst race and region, race and provider-location type, region and provider-location
type, and the interaction between race and region, shows that the attitudes and
perceptions discussed within the HBM, can have a significant effect on certain factors
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pertaining to HPV vaccination uptake amongst adolescent. Additionally, the results of the
study provides the groundwork for identifying strategies used by the factors of race,
provider-location and region, resulting in an increased HPV vaccination amongst
adolescents. The specific factors included, White race adolescents, receiving HPV
vaccination in the Northeast, South and Midwest regions, White race and Black race
adolescents receiving HPV vaccination at public, hospital, private and mixed facilities;
and adolescents that reside in the Northeast, and Midwest region, that receive HPV
vaccination at public, private or hospital facilities. Conducting further research and
identifying the strategies that are used among the aforementioned variables and
ultimately applying them to the underperforming strategies will address each construct of
the HBM and increase HPV vaccination in adolescents, among all races, all regions, and
all provider-location types.
Limitations of the Study
The study showed that 52% of provider-location types were missing. This is a
limitation of the study as it is more than half of the participants. If this information were
included in the survey, it may have changed the trajectory of the provider-location type
results. There is also a limitation on positively concluding that increased HPV
vaccination among adolescents were a definite result of race, region, and providerlocation type.
An additional limitation of this study is generalizability. Generalizability is the
degree to which the results of the sample of participants used for a research study reflect
what the results would be “in the real world” (Frey, 2018). Generalizability in this study
includes the inability to survey the entire population of the United States, and the
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limitations from individuals who do not have access to a landline telephone, which was
the way in which the survey was conducted. Ultimately, this can result in the results
being unrepresentative of the population, which results in lack of generalizability. Lastly,
the final limitation is the reporting of inaccuracies in responses, this may cause validity
and reliability issues; CDC attempts to prevent these issues by conducting follow-up with
providers following the survey.
Recommendations
The recommendations of this study, include further research conducted to identify
specific strategies among White and Black race adolescents who received HPV
vaccinations at public, hospital, and private facilities. Additionally, further research
should identify specific strategies among White race adolescents residing in the
Northeast, Midwest, and Southern region. Further research should look into the strategies
used for adolescents residing in the Northeast and Midwest that received an HPV vaccine
at a public, hospital and private facilities. This research will aid in increasing HPV
vaccination rates among adolescents other/multiple race adolescents, and adolescents
residing in the West, and those seeking care in STD/school/teen clinics and mixed
facilities.
There should also be a cohesive strategy used across the races, regions, and
provider-location type, to obtain a cohesive result of increased HPV vaccination amongst
adolescents. Education, awareness, and accessibility should be further researched as this
may lead to further investigations into the barriers experienced amongst the different
variables.
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This study can help target the states, providers, and races across the country that
have an increased HPV vaccination rates and those that are lagging, and can aid in
determining whether a cohesive effect exists, and whether there are specific strategies in
the well performing HPV vaccination areas that can be relayed and transferred to the
HPV vaccination underperforming areas.
Implications
It has been defined that the premise of positive social change is the intent of
creating and applying ideas, strategies, and actions to promote the worth, dignity, and
development of individuals, communities, organizations, institutions, cultures, and
societies, through a series of processes (Walden University, 2020). In this study there are
several implications for positive socials changes. The potential impact for social change
at the organizational level can be accomplished with identifying races, provider-location
types, and regions that have increased HPV vaccination and understanding the strategies
that can be relayed to underperforming variables. This will enable increased performance
for those variables that are lagging and ultimately an increase in HPV vaccination
amongst adolescents which will also lead to individualized social change.
This study will aid in identifying areas of increased HPV vaccination rate, and
ultimately lead to an understanding of the strategies that are most successful for further
research; this will help increase HPV vaccination across the United States, consistently.
This will also prevent certain cancers and decease cancer rates amongst both, women and
men.
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Conclusion
The HPV vaccine is a significant public health advancement that has the ability to
prevent recurring HPV infection and ultimately save many lives. This results of this study
showed that race and region had a statistically significant effect on HPV vaccination
uptake amongst adolescents; specifically, White race, the Northeast, Midwest, and the
Southern regions were shown to be statistically significant. This study also showed that
race and provider-location type had a statistically significant effect on HPV vaccine
uptake amongst adolescents, specifically, the White and Black race was shown to be
significant, in addition to all public facilities, all hospital facilities, all private facilities,
and a mixture of facilities. This study also showed that provider-location type and region
were shown to be statistically significant; specifically, the Northeast region, and the
Midwest region were shown to be significant, in addition to all public facilities, all
hospital facilities, and all private facilities. Lastly, the results of this study showed that
the interaction between race and region were found to be statistically significant in its
effect on HPV vaccination amongst adolescents.
This study was conducted to determine the various factors that have an effect on
HPV vaccination uptake amongst adolescents. The areas where there is an increased level
of HPV uptake were determined using a binary logistic regression, and assisted with
determining the areas where HPV vaccination rates were lagging. This ultimately will aid
in determining the strategies being used that are positively increasing HPV vaccination
rates in adolescents, and sharing those strategies with the areas that are lagging. This
study provides the background information and foundation base for further research in
determining the strategies, and whether those strategies increase HPV vaccination rates in
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those areas. HPV is vital for the health of men and women, and it is my thought that with
increased HPV vaccination rates in adolescence, will undoubtedly lead to the prevention
of certain cancers and ultimately save many lives.
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Appendix A: Questions from the 2018 NIS Used for This Study
Questions 1 will provide variables related to HPV vaccination.
Q1: Has [TEEN] ever received HPV shots?
1. Yes
2. No
3. Don’t Know
4. Refused
Questions 5 will provide the variables related to race.
Q5: Is [TEEN] White, Black or African American, American Indian, Alaska Native,
Asian, Native Hawaiian or Pacific Islander?
1. White
2. Black/African American
3. American Indian
4. Alaska Native
5. Asian
6. Native Hawaiian
7. Pacific Islander
8. Other
9. Don’t Know
10. Refused
1. Refused
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Questions 9-12 will provide the variables related to Region of the United States.
Q9: What is your zip code?
1. ____
2. Don’t Know
3. Refused
Q10: In what city, county, and state do you live?
1. Enter City
2. Enter County
3. Enter State
Q11: To confirm, you live in [CITY}, [COUNTY], [STATE]. Is that correct?
1. Yes
2. No
Q12: To confirm, I have your zip code as ______. Is that correct?
1. Yes
2. No
3. Don’t Know
4. Refused
Question 13 will provide the variables for provider-location type?
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Q13: Please tell me all the types of places where [TEEN} has received an HPV shot: This
question is referring to the location of the vaccine provider, not to the location on the
body where the shot was given.
1. Doctor’s Office
2. Emergency Room
3. Health Department
4. Clinic or Health Center
5. Hospital-Based Clinic
6. While Hospitalized
7. Other Medically Related Place
8. Pharmacy, Drug Store, or Supermarket Pharmacy
9. Workplace
10. Elementary/Middle/High School
11. Other Non-medically related place
12. Mall Outreach
13. Village Outreach (Guam)
14. Don’t Know
15. Refused

